The Fleming Fund is working with Uganda’s health care system to break down the barriers to disease surveillance by strengthening laboratory and diagnostic capacity in antimicrobial resistance (AMR) - leveraging in-country infrastructure and sustainability - for global health security.
Promoting sustainability of the supply of reagents and consumables for AMR surveillance
Since 2017, the Fleming Fund has adopted a comprehensive systems-strengthening approach, investing in laboratory infrastructure, human resources, data production and use, and governance mechanisms.
Effective AMR surveillance requires the consistent generation of quality-assured bacteriology data and its systematic application to clinical guidelines, essential medicines lists, and policy processes.
A critical determinant of sustainability remains the financing of laboratory consumables; without adequate domestic investment, testing capacity is at risk. In response, the programme has supported countries undertaking political economy analyses, strengthening cost forecasting, and enhancing resource mobilisation.
As the programme concludes, national stakeholders are assessing achievements and identifying priority actions to ensure the continuity of reagent and consumable supply chains, with broader implications for health system resilience. Recent analysis of supply chain challenges for reagents and consumables highlights broader lessons for health system resilience and the importance of securing long-term, reliable access to the inputs that enable global AMR surveillance.
Promoting sustainability of the supply of reagents and consumables for AMR surveillance
View pdf Promoting sustainability of the supply of reagents and consumables for AMR surveillance (191.33 KB)More Like This
Programme Update
From Programme Update, Case Study: Breaking down AMR barriers in Uganda , Date: 05/08/2022
As part of World Antimicrobial Awareness Week 2022 in November last year, Head of the Fleming Fund’s Expert Advisory Group Dr Catriona Waddington joined an esteemed panel of speakers from the AMR community at the symposium, ‘The rising tide of antimicrobial resistance – a high price to pay’ hosted by Ineos Oxford Institute, Oxford Martin School.